Chen Zhe-Sheng, Guo Yanping, Belinsky Martin G, Kotova Elena, Kruh Gary D
Medical Science Division, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111, USA.
Mol Pharmacol. 2005 Feb;67(2):545-57. doi: 10.1124/mol.104.007138. Epub 2004 Nov 10.
We previously determined that expression of human multidrug resistance protein (MRP) 8, a recently described member of the MRP family of ATP-binding cassette transporters, enhances cellular extrusion of cyclic nucleotides and confers resistance to nucleotide analogs (J Biol Chem 278:29509-29514, 2003). However, the in vitro transport characteristics of the pump have not been determined. In this study, the substrate selectivity and biochemical activity of MRP8 is investigated using membrane vesicles prepared from LLC-PK1 cells transfected with MRP8 expression vector. Expression of MRP8 is shown to stimulate the ATP-dependent uptake of a range of physiological and synthetic lipophilic anions, including the glutathione S-conjugates leukotriene C4 and dinitrophenyl S-glutathione, steroid sulfates such as dehydroepiandrosterone 3-sulfate (DHEAS) and estrone 3-sulfate, glucuronides such as estradiol 17-beta-D-glucuronide (E(2)17betaG), the monoanionic bile acids glycocholate and taurocholate, and methotrexate. In addition, MRP8 is competent in the in vitro transport of cAMP and cGMP, in accord with the results of our previously reported cellular studies. DHEAS, E(2)17betaG, and methotrexate were transported with K(m) and V(max) values of 13.0 +/- 0.8 microM and 34.9 +/- 9.5 pmol/mg/min, 62.9 +/- 12 microM and 62.0 +/- 5.2 pmol/mg/min, and 957 +/- 28 microM and 317 +/- 17 pmol/mg/min, respectively. Based upon the stimulatory action of DHEAS on uptake of E(2)17betaG, the attenuation of this effect at high DHEAS concentrations and the lack of reciprocal promotion of DHEAS uptake by E(2)17betaG, a model involving nonreciprocal constructive interactions between some transport substrates is invoked. These results suggest that MRP8 participates in physiological processes involving bile acids, conjugated steroids, and cyclic nucleotides and indicate that the pump has complex interactions with its substrates.
我们先前已确定,人多药耐药蛋白(MRP)8(ATP结合盒转运体MRP家族中最近描述的一个成员)的表达可增强细胞对环核苷酸的外排,并赋予对核苷酸类似物的抗性(《生物化学杂志》278:29509 - 29514,2003年)。然而,该转运蛋白的体外转运特性尚未确定。在本研究中,利用转染了MRP8表达载体的LLC - PK1细胞制备的膜囊泡,研究了MRP8的底物选择性和生化活性。结果表明,MRP8的表达可刺激一系列生理性和亲脂性合成阴离子的ATP依赖性摄取,这些阴离子包括谷胱甘肽S - 共轭物白三烯C4和二硝基苯基S - 谷胱甘肽、类固醇硫酸盐如硫酸脱氢表雄酮(DHEAS)和硫酸雌酮、葡糖醛酸苷如17 - β - D - 葡糖醛酸雌二醇(E(2)17βG)、单阴离子胆汁酸甘氨胆酸和牛磺胆酸以及甲氨蝶呤。此外,与我们先前报道的细胞研究结果一致,MRP8在体外可转运cAMP和cGMP。DHEAS、E(2)17βG和甲氨蝶呤的转运K(m)值和V(max)值分别为13.0±0.8 μM和34.9±9.5 pmol/mg/min、62.9±12 μM和62.0±5.2 pmol/mg/min以及957±28 μM和317±17 pmol/mg/min。基于DHEAS对E(2)17βG摄取的刺激作用、高浓度DHEAS时该效应的减弱以及E(2)17βG对DHEAS摄取缺乏相互促进作用,提出了一个涉及某些转运底物之间非相互建设性相互作用的模型。这些结果表明,MRP8参与涉及胆汁酸、共轭类固醇和环核苷酸的生理过程,并表明该转运蛋白与其底物具有复杂的相互作用。